Funding from My Room will support MyeChild01, an international trial for children diagnosed with leukaemia.
ANZCHOG is delighted to announce that funding awarded by My Room will enable Australian and New Zealand children diagnosed with Acute Myeloid Leukaemia (AML) access to the latest international trial, MyeChild01.
The trial will test which current treatment when combined with a novel therapeutic agent (only available through the MyeChild01 trial) will provide the best outcome for children diagnosed with AML.
For further details, please see the attached media release. ANZCHOG media release: My Room and MyeChild01